FierceBiotech ٢٥ نوفمبر ٢٠٢٥ <a href="https://www.fiercebiotech.com/pharma/novos-shares-tumble-8-after-2-trial-misses-semaglutide-alzheimers-disease" hreflang="en">Novo shares tumble after 2 trial misses for semaglutide in Alzheimer's disease</a> #Alzheimer disease #Novo Nordisk
Endpoints News ٢٤ نوفمبر ٢٠٢٥ Novo Nordisk's semaglutide misses in closely-watched Alzheimer’s trials #Novo Nordisk #closely-watched Alzheimer
BioWorld ٢٤ نوفمبر ٢٠٢٥ Novo’s semaglutide fails in phase III Alzheimer’s trials #phase III #III Alzheimer
BioPharma Dive ٢٤ نوفمبر ٢٠٢٥ Novo Nordisk’s GLP-1 misses goal in closely watched Alzheimer’s studies #Novo Nordisk #watched Alzheimer
Endpoints News ٢١ نوفمبر ٢٠٢٥ Novo, Lilly begin to sell obesity medications directly to employers #Novo Nordisk #Eli Lilly
Lonza News ٧ أكتوبر ٢٠٢٥ Biotechnology Market Therapeutic Innovations & Forecast Report 2025-2033 Featuring Lonza, Amgen, Syngenta, Biocon, Biogen, F. Hoffmann-La Roche, Novartis, Novo Nordisk A/S, Pfizer, and Seagen - ResearchAndMarkets.com - Business Wire #Therapeutic Innovations #Forecast Report